A Phase II Clinical Study of mFOLFOX6 /XELOX as Adjuvant Chemotherapy after Curative Resection of Stage III Colon Cancer: The FACOS Study

This clinical study is being conducted to verify the efficacy and safety of oxaliplatin combined with a fluoropyrimidine derivative as adjuvant chemotherapy for patients with stage III colon cancer, since few clinical data are available for Japanese patients. The mFOLFOX6 and XELOX regimens are bein...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Annals of Cancer Research and Therapy 2016/01/13, Vol.24(1), pp.17-22
Hauptverfasser:	Ishibashi, Keiichiro, Kumamoto, Kensuke, Koda, Keiji, Kato, Hiroyuki, Nishimura, Genichi, Yoshimatsu, Kazuhiko, Yokomizo, Hajime, Ooki, Shinji, Tanaka, Soichi, Asano, Michio, Yokoyama, Masaru, Kawada, Tomoyuki, Ishida, Hideyuki
Format:	Artikel
Sprache:	eng
Schlagworte:	adjuvant chemotherapy colon cancer oxaliplatin
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!